ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,611Medicare Part D Prescriptions Filled, Including Refills

Rank: 777 out of 2343

$530K Total Retail Price of All Prescriptions

Rank: 606 out of 2343

643 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 643 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 643 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,853 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 377 344 1 1
LEVOTHYROXINE SODIUM 337 331 2 2
AMLODIPINE BESYLATE 213 197 3 5
OMEPRAZOLE 204 161 4 4
LISINOPRIL 185 173 5 3
ATORVASTATIN CALCIUM 174 171 6 10
LOSARTAN POTASSIUM 153 150 7 19
CRESTOR 148 139 8 30
SERTRALINE HCL 147 123 9 20
HYDROCHLOROTHIAZIDE 141 127 10 11
METFORMIN HCL 138 117 11 9
METOPROLOL SUCCINATE 132 126 12 14
FUROSEMIDE 132 120 12 6
LOSARTAN-HYDROCHLOROTHIAZIDE 130 93 14 64
DONEPEZIL HCL 123 123 15 21
METOPROLOL TARTRATE 114 103 16 7
ATENOLOL 105 79 17 12
ZOLPIDEM TARTRATE 104 100 18 24
PAROXETINE HCL 101 89 19 66
WARFARIN SODIUM 98 89 20 8
SYNTHROID 97 94 21 40
ISOSORBIDE MONONITRATE ER 90 89 22 32
NAMENDA 82 82 23 36
PRAVASTATIN SODIUM 81 77 24 15
TAMSULOSIN HCL 71 70 25 29
HYDROCODONE-ACETAMINOPHEN 68 35 S3 26 13
DIOVAN 68 68 26 23
METHYLPREDNISOLONE 65 62 28 122
DOXAZOSIN MESYLATE 65 63 28 98
PREDNISONE 64 57 30 37
VENLAFAXINE HCL ER 64 60 30 87
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 62 32 42
AZITHROMYCIN 62 58 33 39
ALLOPURINOL 61 61 34 31
CARVEDILOL 58 58 35 27
TRAMADOL HCL 53 46 36 25
GABAPENTIN 52 42 37 16
PROPRANOLOL HCL 52 44 37 132
LOVASTATIN 50 50 39 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 15, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.